Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Affect Disord. 2017 Jan 11;216:17–29. doi: 10.1016/j.jad.2016.12.046

Table 5.

Meta-component characteristics (*** = p < 0.001, ** = p < 0.01, * = p < 0.05, . = p <0.1)

Coefficients: B SEM t value Pr(>|t|)
Component 1 (Intercept) 1.06 1.21 0.88 0.38
F(7,81) = 0.7156, p = 0.6589 Gender −0.23 0.24 −0.97 0.34
Adj R^2 = 0.02314 Site (1=UCSD,2=UCLA) −0.13 0.22 −0.59 0.56
Negative valence symptoms, approach bias, high sustained, selective attention Age −0.01 0.01 −1.20 0.24
No Medication −0.03 0.99 −0.03 0.98
Benzodiazepine −0.62 1.12 −0.55 0.58
SSRI −0.15 1.03 −0.15 0.88
Other −0.43 1.05 −0.41 0.69
Component 2 (Intercept) −2.00 1.10 −1.82 0.07.
F(7,81) = 0.7156, p = 0.1604 Gender 0.09 0.21 0.44 0.67
Adj R^2 = 0.04238 Site (1=UCSD,2=UCLA) 0.15 0.20 0.76 0.45
Positive Valence symptoms, approach bias, slow selective, sustained attention Age −0.02 0.01 −1.93 0.06.
No Medication 2.16 0.90 2.40 0.02*
Benzodiazepine 2.07 1.01 2.04 0.04*
SSRI 1.96 0.94 2.09 0.04*
Other 2.31 0.96 2.42 0.02*
WHODAS 2.0 (Intercept) 22.21 0.71 31.47 < 2e-16***
F(2,88) = 7.80, p <0.0007591 Meta-Component 1 2.82 0.74 3.80 0.00***
Adj R^2 =0.1313 Meta-Component 2 −0.90 0.80 −1.14 0.25